February 2017 FDA Recall Drug by Sandoz Inc
D-0481-2017 - Labeling

This Class II drug recall was voluntarily initiated by Sandoz Inc on February 2, 2017 for the product Drug. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0481-2017

Reason for Recall
Labeling: Incorrect Instructions:outer carton contains the incorrect instructions for Step 2 stating "Do cut the patch" rather than the correct instructions of "Do not cut the patch". The pouch containing the patch is labeled correctly.
Initiated
02-02-2017
Reported
03-01-2017
Quantity
157,922 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide in the USA and Puerto Rico
Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 1 patch per pouch (NDC 66758-208-58), packaged in 4-count patches per carton (NDC 66758-208-54), Rx Only, Manufactured by ALZA Corporation, Vacaville, CA 95688 for Sandoz Inc., Princeton, NJ 08540.

Batch or Lot Expiration Information

Lot# : 6323Q11, 6328Q11, Exp 06/19; 6355Q11, Exp 07/19